Clin2
NCT07157631Possibly a fitRecruiting

Tranexamic acid for adults having liver transplant

Liver TransplantationTranexamic AcidEnd-stage Liver Disease (ESLD)

Treatments studied

Part of Digestive system clinical trials.

This trial tests if tranexamic acid, a medicine that helps blood clot, can safely reduce bleeding during adult liver transplant surgery.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
1,546 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are 18 years or older.
  • You are scheduled to receive a new liver from a donor (allogeneic liver transplant).
  • You will have general anesthesia for the surgery.
  • You have no history of blood clots in an artery or vein in the past 3 months.
  • You have not had a previous liver transplant.
  • You are not allergic to tranexamic acid.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06657924Recruiting· Phase 2
TXA to Prevent Bleeding in Colorectal Surgery

This trial tests a medicine called tranexamic acid (TXA) given right before major colorectal surgery to see if it helps reduce bleeding. If it works, it could make surgery safer for people like you.

Cleveland, Ohio
NCT06023212Recruiting· Phase 1/Phase 2
Tranexamic acid to prevent bleeding in spine surgery for lung cancer

This trial tests if a medicine called tranexamic acid can help reduce bleeding during surgery for lung cancer that has spread to the spine. It may be an option if you have a single tumor in your spine and are having separation surgery.

Hangzhou, Zhejiang
NCT06414031Recruiting· Phase 3
Transfusion reduction in abdominal surgery with tranexamic acid

This trial tests whether a medicine called tranexamic acid can help reduce the need for blood transfusions during major abdominal surgeries. It's for people having surgery to remove part of the esophagus, stomach, colon, rectum, pancreas, or liver.

Dresden, Saxony
NCT07164300Recruiting
Tranexamic acid dosing study in heart surgery

This study compares different doses of tranexamic acid, a medicine that reduces bleeding, in patients having planned heart surgery with a heart-lung machine. It aims to find the best dose to prevent blood loss.

Ioannina
NCT03553186Recruiting· Phase 3
Tranexamic acid to reduce bleeding in spine surgery

This Phase 3 trial tests whether tranexamic acid can reduce bleeding during major spine fusion surgery for adults with scoliosis or spine degeneration. It may help lessen blood loss and the need for transfusions, while monitoring safety.

New York, New York
NCT06422273Enrolling by invitation· Phase 3
TXA vs Saline to Prevent Bleeding After Lung Transplant Biopsy

This trial tests whether a medication called tranexamic acid (TXA) can help prevent bleeding after a lung transplant biopsy. It compares TXA to a saltwater solution (saline) to see if it reduces the need for procedures to stop bleeding.

Grand Rapids, Michigan

Hear when a new Liver Transplantation trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.